Journal Mobile Options
Table of Contents
Vol. 38, No. 1, 1997
Issue release date: 1997
Eur Neurol 1997;38:44–48

The Perceived Effects of Smoked Cannabis on Patients with Multiple Sclerosis

Consroe P. · Musty R. · Rein J. · Tillery W. · Pertwee R.
Departments of a Pharmacology/Toxicology and b Academic Resources, University of Arizona Health Sciences Center, Tucson, Ariz., c Department of Psychology, University of Vermont, Burlington, Vt., USA; d Institute of Medical Sciences, University of Aberdeen, Scotland, UK

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Fifty-three UK and 59 USA people with multiple sclerosis (MS) answered anonymously the first questionnaire on cannabis use and MS. From 97 to 30% of the subjects reported cannabis improved (in descending rank order): spasticity, chronic pain of extremities, acute paroxysmal phenomenon, tremor, emotional dysfunction, anorexia/weight loss, fatigue states, double vision, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance, and memory loss. The MS subjects surveyed have specific therapeutic reasons for smoking cannabis. The survey findings will aid in the design of a clinical trial of cannabis or cannabinoid administration to MS patients or to other patients with similar signs or symptoms.

 goto top of outline Author Contacts

Professor Paul Consroe, Department of Pharmacology/Toxicology, College of Pharmacy, University of Arizona, PO Box 210207, Tucson, AZ 85721-0207 (USA), Tel. (520) 6262884, Fax (520) 6262466, E-Mail

 goto top of outline Article Information

Received: August 19, 1996
Accepted: February 14, 1997
Published online: December 20, 2007
Number of Print Pages : 5

 goto top of outline Publication Details

European Neurology

Vol. 38, No. 1, Year 1997 (Cover Date: 1997)

Journal Editor: Bogousslavsky, J. (Montreux)
ISSN: 0014–3022 (print), 1421–9913 (Online)

For additional information:

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50